Xconomy Boston

Kolltan Pharmaceuticals Inc Receives $35,000,000 Series A Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=52d34df6-d01d-4788-ac80-e87accbaf87c&Preview=1
Date
1/9/2009
Company Name
Kolltan Pharmaceuticals Inc
Mailing Address
50 Rock Hill Road Woodbridge, CT 06525
Company Description
Kolltan is a development-stage company advancing therapeutics that target well-defined and validated molecular mechanisms of disease in areas of critical clinical need.
Website
Undisclosed
Transaction Type
Venture Equity
Transaction Amount
$35,000,000
Transaction Round
Series A
Proceeds Purposes
The proceeds of the Series A financing will be used to advance Kolltan’s therapeutic development pipeline.
M&A Terms
Venture Investor
Undisclosed